Moyamoya disease is a rare progressive cerebrovascular disease characterized by bilateral occlusion and narrowing of arteries forming the Willis polygon. Because of the appearance of the collateral vessels in the cerebral angiogram, the disease means cigarette smoke in Japanese.
Moyamoya disease is a rare progressive cerebrovascular disease characterized by bilateral occlusion and narrowing of arteries forming the Willis polygon. Because of the appearance of the collateral vessels in the cerebral angiogram, the disease is called Moyamoya, which means cigarette smoke in Japanese.
The starting age for children is 4-14. Moyamoya disease is usually associated with ischemic cerebrovascular stroke in children. In childhood, stroke, transient ischemic attacks are usually associated with ischemic sequelae, and neurological symptoms including motor deficit, sensory impairment, involuntary movement, recurrent headaches, seizures and cognitive disorders may occur.
Recurrent strokes can lead to severe functional disorders or even death, so early identification and treatment of lesions is important. Stroke is rare in childhood, with an incidence of 2.5-2.7 per 100,000 people per year. Moyamoya disease is mostly seen in Asians, the etiology is unknown.
In children; Symptoms and findings can vary widely. These findings can range from temporary ischemic attacks (temporary paralysis) to persistent neurological problems. There are some factors that can cause quick and deep breathing that make it easier for the symptoms to appear.
In these patients, headache, epilepsy (epilepsy) can sometimes be the only symptom and therefore can be mixed with sequelae of cerebral palsy. However, cognitive impairment (loss of ability to comprehend, reasoning, planning, etc.) in this disorder is observed in almost all cases, seen in children and adulthood groups.
Diagnosis of the disease is made by computed tomography (CT), magnetic resonance imaging (MRI), MR angiography and positron emission tomography (PET).
There is no effective medical treatment yet. However, a variety of medicines are used for the determined findings. The medical treatment is to prevent the intended patient from having another brain hemorrhage. Treatment differs in childhood and adult populations due to the different rates of aneurysm and bleeding. In Cerrehisinde revascularization surgery is performed. Despite the positive results regarding this surgical technique, scientific studies continue.
The physiotherapy of the moyamoya disease includes the symptomatic approaches. Due to the high frequency of stroke, it should be treated by specialist physiotherapists in the field of neurological physiotherapy. Muscle strengthening, balance, sensory training, spasticity control and postural straightness are among the main targets.
There are two studies on the physiotherapy of the moyamoya disease with our work done up to now. We had a significant improvement in the rough motor function of a Moyamoya patient we treated in eight months.
We would like to add motion to life in MOYAMOYA’s patients with the happiness of supporting our work. It should not be forgotten that physiotherapy should be started as early as possible with medical treatment.